NEUP Stock Analysis: Buy, Sell, or Hold?
NEUP - Neuphoria Therapeutics Inc. Common Stock
$4.02
0.00 (0.00%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 13, 2026
11d
Get Alerted When NEUP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: NEUP shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: NEUP shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: NEUP is currently trading at $4.02, which is considered fair relative to its 30-day fair value range of $3.85 to $4.14.
Technical Outlook: Technically, NEUP is in a strong downtrend. The price is currently testing key support at $3.98. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.77 (+143.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NEUP is in a strong downtrend. The price is currently testing key support at $3.98. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.77 (+143.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$3.85 -
$4.14
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 143.0% below Wall St target ($9.77)
Fair Price Analysis
30-Day Fair Range
$3.85 -
$4.14
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$3.98
Resistance Level
$4.25
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.05
Wall Street Target
$9.77
(+143.0%)
Profit Margin
-60.5%
Last updated: February 01, 2026 6:00 AM ET
Data refreshes hourly during market hours. Next update: 7:00 AM
Data refreshes hourly during market hours. Next update: 7:00 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NEUP showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Lynx1 Capital Management…
BUY
639110 shares
2025-10-21
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
Advanced NEUP Option Strategies
Professional options setups generated by AI based on today's NEUP price and gamma walls.
